Spots Global Cancer Trial Database for Clinical Effects of Metformin on Fertility-sparing Treatment for Early Endometrial Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Clinical Effects of Metformin on Fertility-sparing Treatment for Early Endometrial Cancer
Official Title: Clinical Effects of Metformin on Fertility-sparing Treatment for Early Endometrial Cancer
Study ID: NCT04792749
Conditions
Interventions
Study Description
Brief Summary: The purpose of the study is to investigate the effects of metformin in addition to the conventional progestin therapy in the fertility-sparing treatment of early stage endometrial cancer.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT
Sex: FEMALE
Healthy Volunteers: Yes
Locations
Samsung Medical Center, Seoul, , Korea, Republic of
Contact Details
Name: Jeong-Won Lee, M.D., Ph.D.
Affiliation: Samsung Medical Center
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
